Rice bioengineer awarded $2.2M for project to develop long-acting cell factory implants for HIV, malaria treatment and prevention
March 12, 2026
March 12, 2026
HOUSTON, Texas, March 12 -- Rice University posted the following news release:
* * *
Rice bioengineer awarded $2.2M for project to develop long-acting cell factory implants for HIV, malaria treatment and prevention
*
Rice University bioengineer Omid Veiseh has been awarded a $2.2 million grant from the Gates Foundation to develop implantable cell factory platforms that can deliver therapeutic antibodies over extended periods of two years or lon . . .
* * *
Rice bioengineer awarded $2.2M for project to develop long-acting cell factory implants for HIV, malaria treatment and prevention
*
Rice University bioengineer Omid Veiseh has been awarded a $2.2 million grant from the Gates Foundation to develop implantable cell factory platforms that can deliver therapeutic antibodies over extended periods of two years or lon . . .
